Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 3 July 1992:
Vol. 257. no. 5066, pp. 88 - 91
DOI: 10.1126/science.1621100

Articles

Science, Vol 257, Issue 5066, 88-91
Copyright © 1992 by American Association for the Advancement of Science


articles

Increased osteoclast development after estrogen loss: mediation by interleukin-6

RL Jilka, G Hangoc, G Girasole, G Passeri, DC Williams, JS Abrams, B Boyce, H Broxmeyer, and SC Manolagas

Department of Veterans Affairs Medical Center, Indiana University School of Medicine, Indianapolis 46202.

Osteoclasts, the cells that resorb bone, develop from hematopoietic precursors of the bone marrow under the control of factors produced in their microenvironment. The cytokine interleukin-6 can promote hematopoiesis and osteoclastogenesis. Interleukin-6 production by bone and marrow stromal cells is suppressed by 17 beta-estradiol in vitro. In mice, estrogen loss (ovariectomy) increased the number of colony-forming units for granulocytes and macrophages, enhanced osteoclast development in ex vivo cultures of marrow, and increased the number of osteoclasts in trabecular bone. These changes were prevented by 17 beta-estradiol or an antibody to interleukin-6. Thus, estrogen loss results in an interleukin-6-mediated stimulation of osteoclastogenesis, which suggests a mechanism for the increased bone resorption in postmenopausal osteoporosis.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
NF-{kappa}B as a Critical Link Between Inflammation and Cancer.
M. Karin (2009)
Cold Spring Harb Perspect Biol 1, a000141
   Abstract »    Full Text »    PDF »
Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures.
L. M. McNamara (2009)
J R Soc Interface
   Abstract »    Full Text »    PDF »
Osteoimmunology: Interactions of the Bone and Immune System.
J. Lorenzo, M. Horowitz, and Y. Choi (2008)
Endocr. Rev. 29, 403-440
   Abstract »    Full Text »    PDF »
Circulating Levels of Inflammatory Markers Predict Change in Bone Mineral Density and Resorption in Older Adults: A Longitudinal Study.
C. Ding, V. Parameswaran, R. Udayan, J. Burgess, and G. Jones (2008)
J. Clin. Endocrinol. Metab. 93, 1952-1958
   Abstract »    Full Text »    PDF »
Polymorphisms in the interleukin-6 receptor gene are associated with bone mineral density and body mass index in Spanish postmenopausal women.
M Bustamante, X Nogues, L Mellibovsky, L Agueda, S Jurado, E Caceres, J Blanch, R Carreras, A Diez-Perez, D Grinberg, et al. (2007)
Eur. J. Endocrinol. 157, 677-684
   Abstract »    Full Text »    PDF »
Stimulation of Cells Derived from Nifedipine-induced Gingival Overgrowth with Porphyromonas gingivalis, Lipopolysaccharide, and Interleukin-1{beta}.
H.-K. Lu, H.-P. Chou, C.-L. Li, M.-Y. Wang, and L.-F. Wang (2007)
Journal of Dental Research 86, 1100-1104
   Abstract »    Full Text »    PDF »
p38 MAPK Signaling in Oral-related Diseases.
C.S. Patil and K.L. Kirkwood (2007)
Journal of Dental Research 86, 812-825
   Abstract »    Full Text »    PDF »
The Complex Role of Estrogens in Inflammation.
R. H. Straub (2007)
Endocr. Rev. 28, 521-574
   Abstract »    Full Text »    PDF »
Assessing Osteolysis with Use of High-Throughput Protein Chips.
A. S. Shanbhag, A. M. Kaufman, K. Hayata, and H. E. Rubash (2007)
J. Bone Joint Surg. Am. 89, 1081-1089
   Abstract »    Full Text »    PDF »
A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency.
B. M. Deasy, A. Lu, J. C. Tebbets, J. M. Feduska, R. C. Schugar, J. B. Pollett, B. Sun, K. L. Urish, B. M. Gharaibeh, B. Cao, et al. (2007)
J. Cell Biol. 177, 73-86
   Abstract »    Full Text »    PDF »
Effects of calcium supplementation on bone loss and fractures in congestive heart failure.
R. J A Frost, C. Sonne, U. Wehr, and H.-U. Stempfle (2007)
Eur. J. Endocrinol. 156, 309-314
   Abstract »    Full Text »    PDF »
Estrogen receptor signaling protects against immune suppression by UV radiation exposure.
S. Widyarini, D. Domanski, N. Painter, and V. E. Reeve (2006)
PNAS 103, 12837-12842
   Abstract »    Full Text »    PDF »
Bone Remodeling in Post-menopausal Osteoporosis.
U.H. Lerner (2006)
Journal of Dental Research 85, 584-595
   Abstract »    Full Text »    PDF »
Tissue-specific expression of estrogen receptors and their role in the regulation of neutrophil infiltration in various organs following trauma-hemorrhage.
H.-P. Yu, T. Shimizu, Y.-C. Hsieh, T. Suzuki, M. A. Choudhry, M. G. Schwacha, and I. H. Chaudry (2006)
J. Leukoc. Biol. 79, 963-970
   Abstract »    Full Text »    PDF »
Plasma Membrane-associated Sialidase Is Up-regulated in Renal Cell Carcinoma and Promotes Interleukin-6-induced Apoptosis Suppression and Cell Motility.
S. Ueno, S. Saito, T. Wada, K. Yamaguchi, M. Satoh, Y. Arai, and T. Miyagi (2006)
J. Biol. Chem. 281, 7756-7764
   Abstract »    Full Text »    PDF »
Effects of Selective Testosterone and Estradiol Withdrawal on Skeletal Sensitivity to Parathyroid Hormone in Men.
H. Lee, J. S. Finkelstein, M. Miller, S. J. Comeaux, R. I. Cohen, and B. Z. Leder (2006)
J. Clin. Endocrinol. Metab. 91, 1069-1075
   Abstract »    Full Text »    PDF »
Can Systemic Diseases Co-induce (Not Just Exacerbate) Periodontitis? A Hypothetical "Two-hit" Model.
L.M. Golub, J.B. Payne, R.A. Reinhardt, and G. Nieman (2006)
Journal of Dental Research 85, 102-105
   Full Text »    PDF »
Different Molecular Mechanisms Underlie Ethanol-Induced Bone Loss in Cycling and Pregnant Rats.
K. Shankar, M. Hidestrand, R. Haley, R. A. Skinner, W. Hogue, C.-H. Jo, P. Simpson, C. K. Lumpkin Jr., J. Aronson, T. M. Badger, et al. (2006)
Endocrinology 147, 166-178
   Abstract »    Full Text »    PDF »
The pathophysiology of the growth plate in juvenile idiopathic arthritis.
V. E. MacRae, C. Farquharson, and S. F. Ahmed (2006)
Rheumatology 45, 11-19
   Abstract »    Full Text »    PDF »
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus.
M. Petri, M. Y. Kim, K. C. Kalunian, J. Grossman, B. H. Hahn, L. R. Sammaritano, M. Lockshin, J. T. Merrill, H. M. Belmont, A. D. Askanase, et al. (2005)
N. Engl. J. Med. 353, 2550-2558
   Abstract »    Full Text »    PDF »
IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice.
C. A. O'Brien, R. L. Jilka, Q. Fu, S. Stewart, R. S. Weinstein, and S. C. Manolagas (2005)
Am J Physiol Endocrinol Metab 289, E784-E793
   Abstract »    Full Text »    PDF »
Low-Grade Inflammation and Estimates of Insulin Resistance during the Menstrual Cycle in Lean and Overweight Women.
C. A. Blum, B. Muller, P. Huber, M. Kraenzlin, C. Schindler, C. De Geyter, U. Keller, and J. J. Puder (2005)
J. Clin. Endocrinol. Metab. 90, 3230-3235
   Abstract »    Full Text »    PDF »
Nuclear Factor-{kappa}B-Dependent Mechanisms in Breast Cancer Cells Regulate Tumor Burden and Osteolysis in Bone.
A. H. Gordon, R. J. O'Keefe, E. M. Schwarz, R. N. Rosier, and J. E. Puzas (2005)
Cancer Res. 65, 3209-3217
   Abstract »    Full Text »    PDF »
Nongenotropic, Anti-Apoptotic Signaling of 1{alpha},25(OH)2-Vitamin D3 and Analogs through the Ligand Binding Domain of the Vitamin D Receptor in Osteoblasts and Osteocytes: MEDIATION BY Src, PHOSPHATIDYLINOSITOL 3-, AND JNK KINASES.
A. M. Vertino, C. M. Bula, J.-R. Chen, M. Almeida, L. Han, T. Bellido, S. Kousteni, A. W. Norman, and S. C. Manolagas (2005)
J. Biol. Chem. 280, 14130-14137
   Abstract »    Full Text »    PDF »
Regulatory effects of estrogen on acute lung inflammation in mice.
C. L. Speyer, N. J. Rancilio, S. D. McClintock, J. D. Crawford, H. Gao, J. V. Sarma, and P. A. Ward (2005)
Am J Physiol Cell Physiol 288, C881-C890
   Abstract »    Full Text »    PDF »
Cross-Talk between the Interleukin-6 and Prostaglandin E2 Signaling Systems Results in Enhancement of Osteoclastogenesis through Effects on the Osteoprotegerin/Receptor Activator of Nuclear Factor-{kappa}B (RANK) Ligand/RANK System.
X.-H. Liu, A. Kirschenbaum, S. Yao, and A. C. Levine (2005)
Endocrinology 146, 1991-1998
   Abstract »    Full Text »    PDF »
Transient Versus Sustained Phosphorylation and Nuclear Accumulation of ERKs Underlie Anti-Versus Pro-apoptotic Effects of Estrogens.
J.-R. Chen, L. I. Plotkin, J. I. Aguirre, L. Han, R. L. Jilka, S. Kousteni, T. Bellido, and S. C. Manolagas (2005)
J. Biol. Chem. 280, 4632-4638
   Abstract »    Full Text »    PDF »
Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-{alpha}-deficient male and female mice.
V. Parikka, Z. Peng, T. Hentunen, J. Risteli, T. Elo, H K. Vaananen, and P. Harkonen (2005)
Eur. J. Endocrinol. 152, 301-314
   Abstract »    Full Text »    PDF »
The Molecular Pharmacology of Estrogen Receptor Modulators: Implications for the Treatment of Breast Cancer.
D. P. McDonnell (2005)
Clin. Cancer Res. 11, 871s-877s
   Abstract »    Full Text »    PDF »
Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole.
A Martinetti, E Bajetta, L Ferrari, N Zilembo, E Seregni, M Del Vecchio, R Longarini, I La Torre, L Toffolatti, D Paleari, et al. (2004)
Endocr. Relat. Cancer 11, 771-779
   Abstract »    Full Text »    PDF »
Raloxifene Modulates Interleukin-6 and Tumor Necrosis Factor-{alpha} Synthesis in Vivo: Results from a Pilot Clinical Study.
W. Gianni, A. Ricci, P. Gazzaniga, M. Brama, M. Pietropaolo, S. Votano, F. Patane, A. M. Agliano, G. Spera, V. Marigliano, et al. (2004)
J. Clin. Endocrinol. Metab. 89, 6097-6099
   Abstract »    Full Text »    PDF »
Menstrual and Reproductive Factors and Risk of Non-Hodgkin's Lymphoma among Connecticut Women.
Y. Zhang, T. R. Holford, B. Leaderer, P. Boyle, S. H. Zahm, B. Zhang, K. Zou, L. M. Morton, P. H. Owens, S. Flynn, et al. (2004)
Am. J. Epidemiol. 160, 766-773
   Abstract »    Full Text »    PDF »
Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome.
G.-J. Shim, M. Warner, H.-J. Kim, S. Andersson, L. Liu, J. Ekman, O. Imamov, M. E. Jones, E. R. Simpson, and J.-A. Gustafsson (2004)
PNAS 101, 12628-12633
   Abstract »    Full Text »    PDF »
Estrogen Deficiency Accelerates Murine Autoimmune Arthritis Associated with Receptor Activator of Nuclear Factor-{kappa}B Ligand-Mediated Osteoclastogenesis.
T. Yoneda, N. Ishimaru, R. Arakaki, M. Kobayashi, T. Izawa, K. Moriyama, and Y. Hayashi (2004)
Endocrinology 145, 2384-2391
   Abstract »    Full Text »    PDF »
Nitric Oxide Donor Increases Osteoprotegerin Production and Osteoclastogenesis Inhibitory Activity in Bone Marrow Stromal Cells from Ovariectomized Rats.
F.-S. Wang, C.-J. Wang, Y.-J. Chen, Y.-T. Huang, H.-C. Huang, P.-R. Chang, Y.-C. Sun, and K. D. Yang (2004)
Endocrinology 145, 2148-2156
   Abstract »    Full Text »    PDF »
The Skeletal Effects of Glucocorticoid Excess Override Those of Orchidectomy in Mice.
R. S. Weinstein, D. Jia, C. C. Powers, S. A. Stewart, R. L. Jilka, A. M. Parfitt, and S. C. Manolagas (2004)
Endocrinology 145, 1980-1987
   Abstract »    Full Text »    PDF »
Metacarpal Cortical Area and Risk of Coronary Heart Disease: The Framingham Study.
E. J. Samelson, D. P. Kiel, K. E. Broe, Y. Zhang, L. A. Cupples, M. T. Hannan, P. W. F. Wilson, D. Levy, S. A. Williams, and V. Vaccarino (2004)
Am. J. Epidemiol. 159, 589-595
   Abstract »    Full Text »    PDF »
Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease.
D. C. Harnish, L. M. Albert, Y. Leathurby, A. M. Eckert, A. Ciarletta, M. Kasaian, and J. C. Keith Jr. (2004)
Am J Physiol Gastrointest Liver Physiol 286, G118-G125
   Abstract »    Full Text »    PDF »
Dexamethasone Enhances Osteoclast Formation Synergistically with Transforming Growth Factor-{beta} by Stimulating the Priming of Osteoclast Progenitors for Differentiation into Osteoclasts.
A. Takuma, T. Kaneda, T. Sato, S. Ninomiya, M. Kumegawa, and Y. Hakeda (2003)
J. Biol. Chem. 278, 44667-44674
   Abstract »    Full Text »    PDF »
Bone Turnover in Prolonged Critical Illness: Effect of Vitamin D.
G. Van den Berghe, D. Van Roosbroeck, P. Vanhove, P. J. Wouters, L. De Pourcq, and R. Bouillon (2003)
J. Clin. Endocrinol. Metab. 88, 4623-4632
   Abstract »    Full Text »    PDF »
Role of Monocytes in Atherogenesis.
B. OSTERUD and E. BJORKLID (2003)
Physiol Rev 83, 1069-1112
   Abstract »    Full Text »    PDF »
Disruption of the estrogen receptor {beta} gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis.
G.-J. Shim, L. Wang, S. Andersson, N. Nagy, L. L. Kis, Q. Zhang, S. Makela, M. Warner, and J.-A. Gustafsson (2003)
PNAS 100, 6694-6699
   Abstract »    Full Text »    PDF »
Modulation of Growth Factor/Cytokine Synthesis and Signaling by 1{alpha},25-Dihydroxyvitamin D3: Implications in Cell Growth and Differentiation.
A. Gurlek, M. R. Pittelkow, and R. Kumar (2002)
Endocr. Rev. 23, 763-786
   Abstract »    Full Text »    PDF »
Characterization of an Antagonist Interleukin-6 Dimer by Stable Isotope Labeling, Cross-linking, and Mass Spectrometry.
T. Taverner, N. E. Hall, R. A. J. O'Hair, and R. J. Simpson (2002)
J. Biol. Chem. 277, 46487-46492
   Abstract »    Full Text »    PDF »
Transcriptional Synergism on the pS2 Gene Promoter between a p160 Coactivator and Estrogen Receptor-{alpha} Depends on the Coactivator Subtype, the Type of Estrogen Response Element, and the Promoter Context.
T. Barkhem, L.-A. Haldosen, J.-A. Gustafsson, and S. Nilsson (2002)
Mol. Endocrinol. 16, 2571-2581
   Abstract »    Full Text »    PDF »
IL-6, Leukemia Inhibitory Factor, and Oncostatin M Stimulate Bone Resorption and Regulate the Expression of Receptor Activator of NF-{kappa}B Ligand, Osteoprotegerin, and Receptor Activator of NF-{kappa}B in Mouse Calvariae.
P. Palmqvist, E. Persson, H. H. Conaway, and U. H. Lerner (2002)
J. Immunol. 169, 3353-3362
   Abstract »    Full Text »    PDF »
Regulation of Receptor Activator of NF-kappa B Ligand-induced Osteoclastogenesis by Endogenous Interferon-beta (INF-beta ) and Suppressors of Cytokine Signaling (SOCS). THE POSSIBLE COUNTERACTING ROLE OF SOCSs IN IFN-beta -INHIBITED OSTEOCLAST FORMATION.
T. Hayashi, T. Kaneda, Y. Toyama, M. Kumegawa, and Y. Hakeda (2002)
J. Biol. Chem. 277, 27880-27886
   Abstract »    Full Text »    PDF »
Estrogen Receptor {alpha} Inhibits IL-1{beta} Induction of Gene Expression in the Mouse Liver.
M. J. Evans, K. Lai, L. J. Shaw, D. C. Harnish, and C. C. Chadwick (2002)
Endocrinology 143, 2559-2570
   Abstract »    Full Text »    PDF »
Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism.
E. Bajetta, A. Martinetti, N. Zilembo, P. Pozzi, I. La Torre, L. Ferrari, E. Seregni, R. Longarini, G. Salvucci, and E. Bombardieri (2002)
Ann. Onc. 13, 1059-1066
   Abstract »    Full Text »    PDF »
Evidence that the IL-6/IL-6 Soluble Receptor Cytokine System Plays a Role in the Increased Skeletal Sensitivity to PTH in Estrogen-Deficient Women.
U. S. Masiukiewicz, M. Mitnick, B. I. Gulanski, and K. L. Insogna (2002)
J. Clin. Endocrinol. Metab. 87, 2892-2898
   Abstract »    Full Text »    PDF »
alpha 2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-beta /Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling.
M. Szweras, D. Liu, E. A. Partridge, J. Pawling, B. Sukhu, C. Clokie, W. Jahnen-Dechent, H. C. Tenenbaum, C. J. Swallow, M. D. Grynpas, et al. (2002)
J. Biol. Chem. 277, 19991-19997
   Abstract »    Full Text »    PDF »
Shedding of the Interleukin-6 (IL-6) Receptor (gp80) Determines the Ability of IL-6 to Induce gp130 Phosphorylation in Human Osteoblasts.
C. Vermes, J. J. Jacobs, J. Zhang, G. Firneisz, K. A. Roebuck, and T. T. Glant (2002)
J. Biol. Chem. 277, 16879-16887
   Abstract »    Full Text »    PDF »
Effect of Estrogen versus Testosterone on Circulating Osteoprotegerin and Other Cytokine Levels in Normal Elderly Men.
S. Khosla, E. J. Atkinson, C. R. Dunstan, and W. M. O'Fallon (2002)
J. Clin. Endocrinol. Metab. 87, 1550-1554
   Abstract »    Full Text »    PDF »
Relationship Between Interleukin-6 Production in the Lungs and Pulmonary Vascular Resistance in Patients With Congestive Heart Failure*.
N. Mabuchi, T. Tsutamoto, A. Wada, M. Ohnishi, K. Maeda, M. Hayashi, and M. Kinoshita (2002)
Chest 121, 1195-1202
   Abstract »    Full Text »    PDF »
Differential Response of Estrogen Receptors alpha and beta to SP500263, a Novel Potent Selective Estrogen Receptor Modulator.
H. Brady, M. Doubleday, L. M. Gayo-Fung, M. Hickman, S. Khammungkhune, A. Kois, S. Lipps, S. Pierce, N. Richard, G. Shevlin, et al. (2002)
Mol. Pharmacol. 61, 562-568
   Abstract »    Full Text »    PDF »
Changes in Proinflammatory Cytokine Activity after Menopause.
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz (2002)
Endocr. Rev. 23, 90-119
   Abstract »    Full Text »    PDF »
Estrogen Inhibition of PTH-Stimulated Osteoclast Formation and Attachment in Vitro: Involvement of Both PKA and PKC.
B.-Y. Liu, P.-W. Wu, F. R. Bringhurst, and J.-T. Wang (2002)
Endocrinology 143, 627-635
   Abstract »    Full Text »    PDF »
Sex Steroids and Bone.
S.C. Manolagas, S. Kousteni, and R.L. Jilka (2002)
Recent Prog. Horm. Res. 57, 385-409
   Abstract »    Full Text »    PDF »
Estrogen restores cellular immunity in injured male mice via suppression of interleukin-6 production.
K. A. N. Messingham, S. A. Heinrich, and E. J. Kovacs (2001)
J. Leukoc. Biol. 70, 887-895
   Abstract »    Full Text »    PDF »
Estrogen Reduces the Depth of Resorption Pits by Disturbing the Organic Bone Matrix Degradation Activity of Mature Osteoclasts.
V. Parikka, P. Lehenkari, M.-L. Sassi, J. Halleen, J. Risteli, P. Harkonen, and H. K. Vaananen (2001)
Endocrinology 142, 5371-5378
   Abstract »    Full Text »    PDF »
Altered Bax expression and decreased apoptosis in bone marrow cells of lupus-susceptible NZB/W mice.
M Nazareth, P Fanti, C Schwach, K Poppenberg, K Janis, and S M Aronica (2001)
Lupus 10, 785-793
   Abstract »    PDF »
IL-6 Negatively Regulates IL-11 Production in Vitro and in Vivo.
I. A. Nakchbandi, M. A. Mitnick, U. S. Masiukiewicz, B. h. Sun, and K. L. Insogna (2001)
Endocrinology 142, 3850-3856
   Abstract »    Full Text »    PDF »
Skeletal Effects of Developmental Lead Exposure in Rats.
M. J. J. Ronis, J. Aronson, G. G. Gao, W. Hogue, R. A. Skinner, T. M. Badger, and C. K. Lumpkin Jr. (2001)
Toxicol. Sci. 62, 321-329
   Abstract »    Full Text »    PDF »
Perspective: Nonreproductive Sites of Action of Reproductive Hormones.
S. C. Manolagas and S. Kousteni (2001)
Endocrinology 142, 2200-2204
   Full Text »    PDF »
17{beta}-Estradiol Stimulates Expression of Osteoprotegerin by a Mouse Stromal Cell Line, ST-2, via Estrogen Receptor-{{alpha}}.
M. Saika, D. Inoue, S. Kido, and T. Matsumoto (2001)
Endocrinology 142, 2205-2212
   Abstract »    Full Text »    PDF »
Cloning and Characterization of a Novel Gene That Is Regulated by Estrogen and Is Associated with Mammary Gland Carcinogenesis.
D. Marcantonio, L. E. Chalifour, M. A. Alaoui-Jamali, L. Alpert, and H. T. Huynh (2001)
Endocrinology 142, 2409-2418
   Abstract »    Full Text »    PDF »
Serum Interleukin 6 Is a Major Predictor of Bone Loss in Women Specific to the First Decade Past Menopause.
C. Scheidt-Nave, H. Bismar, G. Leidig-Bruckner, H. Woitge, M. J. Seibel, R. Ziegler, and J. Pfeilschifter (2001)
J. Clin. Endocrinol. Metab. 86, 2032-2042
   Abstract »    Full Text »
The Effects of Particulate Wear Debris, Cytokines, and Growth Factors on the Functions of MG-63 Osteoblasts.
C. Vermes, R. Chandrasekaran, J. J. Jacobs, J. O. Galante, K. A. Roebuck, and T. T. Glant (2001)
J. Bone Joint Surg. Am. 83, 201
   Abstract »    Full Text »
The soluble interleukin 6 receptor: mechanisms of production and implications in disease.
S. A. JONES, S. HORIUCHI, N. TOPLEY, N. YAMAMOTO, and G. M. FULLER (2001)
FASEB J 15, 43-58
   Abstract »    Full Text »    PDF »
Sex Steroids and Bone.
J. E. Compston (2001)
Physiol Rev 81, 419-447
   Abstract »    Full Text »    PDF »
Serotonin Increases Interleukin-6 Synthesis in Human Vascular Smooth Muscle Cells.
T. Ito, U. Ikeda, M. Shimpo, K. Yamamoto, and K. Shimada (2000)
Circulation 102, 2522-2527
   Abstract »    Full Text »    PDF »
Estrogen Deficiency, Obesity, and Skeletal Abnormalities in Follicle-Stimulating Hormone Receptor Knockout (FORKO) Female Mice.
N. Danilovich, P. S. Babu, W. Xing, M. Gerdes, H. Krishnamurthy, and M. R. Sairam (2000)
Endocrinology 141, 4295-4308
   Abstract »    Full Text »    PDF »
Anti-interleukin 6 receptor antibody treatment in rheumatic disease.
N. Nishimoto, T. Kishimoto, and K. Yoshizaki (2000)
Ann Rheum Dis 59, i21-27
   Abstract »    Full Text »    PDF »
Therapeutic Approaches to Bone Diseases.
G. A. Rodan and T. J. Martin (2000)
Science 289, 1508-1514
   Abstract »    Full Text »
Progression of Aortic Calcification Is Associated With Metacarpal Bone Loss During Menopause : A Population-Based Longitudinal Study.
A. E. Hak, H. A. P. Pols, A. M. van Hemert, A. Hofman, and J. C. M. Witteman (2000)
Arterioscler Thromb Vasc Biol 20, 1926-1931
   Abstract »    Full Text »    PDF »
Estrogen Modulates Parathyroid Hormone-Induced Interleukin-6 Production in Vivo and in Vitro.
U. S. Masiukiewicz, M. Mitnick, A. B. Grey, and K. L. Insogna (2000)
Endocrinology 141, 2526-2531
   Abstract »    Full Text »    PDF »
Altered bone marrow cell sensitivity in the lupus-prone NZB/W mouse: regulation of CFU-GM colony formation by estrogen, tamoxifen and thrombopoietin.
S M Aronica, A Dozier, P Fanti, and M Nazareth (2000)
Lupus 9, 271-277
   Abstract »    PDF »
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis.
S. C. Manolagas (2000)
Endocr. Rev. 21, 115-137
   Abstract »    Full Text »
Stimulation of Bone Formation in Vitro and in Rodents by Statins.
G. Mundy, R. Garrett, S. Harris, J. Chan, D. Chen, G. Rossini, B. Boyce, M. Zhao, and G. Gutierrez (1999)
Science 286, 1946-1949
   Abstract »    Full Text »
Editorial: Cell Number Versus Cell Vigor--What Really Matters to a Regenerating Skeleton?.
S. C. Manolagas (1999)
Endocrinology 140, 4377-4381
   Full Text »
The Expression of Interleukin-6 (IL-6), IL-6 Receptor, and gp130-Kilodalton Glycoprotein in the Rat Decidua and a Decidual Cell Line: Regulation by 17{beta}-Estradiol and Prolactin.
S. Deb, C. Tessier, A. Prigent-Tessier, U. Barkai, S. Ferguson-Gottschall, R. K. Srivastava, J. Faliszek, and G. Gibori (1999)
Endocrinology 140, 4442-4450
   Abstract »    Full Text »
A Role for Interleukin-6 in Parathyroid Hormone-Induced Bone Resorption in Vivo.
A. Grey, M.-A. Mitnick, U. Masiukiewicz, B.-H. Sun, S. Rudikoff, R. L. Jilka, S. C. Manolagas, and K. Insogna (1999)
Endocrinology 140, 4683-4690
   Abstract »    Full Text »
The Endocrinology of Aging.
H. M. Perry III (1999)
Clin. Chem. 45, 1369-1376
   Abstract »    Full Text »    PDF »
Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption.
H. Yoshitake, S. R. Rittling, D. T. Denhardt, and M. Noda (1999)
PNAS 96, 8156-8160
   Abstract »    Full Text »    PDF »
STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-kappa B Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone.
C. A. O'Brien, I. Gubrij, S.-C. Lin, R. L. Saylors, and S. C. Manolagas (1999)
J. Biol. Chem. 274, 19301-19308
   Abstract »    Full Text »    PDF »
Estrogen Deficiency Accelerates Autoimmune Exocrinopathy in Murine Sjogren's Syndrome through Fas-Mediated Apoptosis.
N. Ishimaru, K. Saegusa, K. Yanagi, N. Haneji, I. Saito, and Y. Hayashi (1999)
Am. J. Pathol. 155, 173-181
   Abstract »    Full Text »    PDF »
CD4+ T Cells and the Proinflammatory Cytokines Gamma Interferon and Interleukin-6 Contribute to Alveolar Bone Loss in Mice.
P. J. Baker, M. Dixon, R. T. Evans, L. Dufour, E. Johnson, and D. C. Roopenian (1999)
Infect. Immun. 67, 2804-2809
   Abstract »    Full Text »    PDF »
Estrogen has rapid tissue-specific effects on rat bone.
R. T. Turner, L. S. Kidder, M. Zhang, S. A. Harris, K. C. Westerlind, A. Maran, and T. J. Wronski (1999)
J Appl Physiol 86, 1950-1958
   Abstract »    Full Text »    PDF »
The Actions and Interactions of Sex Steroids and Growth Factors/Cytokines on the Skeleton.
T. C. Spelsberg, M. Subramaniam, B. L. Riggs, and S. Khosla (1999)
Mol. Endocrinol. 13, 819-828
   Full Text »
Role of the Osteoclast at the Bone-Implant Interface.
C. Minkin and V.C. Marinho (1999)
Advances in Dental Research 13, 49-56
   Abstract »    PDF »
Amenorrheic Bone Loss.
K. K. Miller and A. Klibanski (1999)
J. Clin. Endocrinol. Metab. 84, 1775-1783
   Full Text »
Selective Effects of Genistein, a Soybean Isoflavone, on B-Lymphopoiesis and Bone Loss Caused by Estrogen Deficiency.
Y. Ishimi, C. Miyaura, M. Ohmura, Y. Onoe, T. Sato, Y. Uchiyama, M. Ito, X. Wang, T. Suda, and S. Ikegami (1999)
Endocrinology 140, 1893-1900
   Abstract »    Full Text »
Parathyroid Hormone-Related Protein (107-139) Stimulates Interleukin-6 Expression in Human Osteoblastic Cells.
F. DE MIGUEL, P. MARTINEZ-FERNANDEZ, C. GUILLEN, A. VALIN, A. RODRIGO, M. E. MARTINEZ, and P. ESBRIT (1999)
J. Am. Soc. Nephrol. 10, 796-803
   Abstract »    Full Text »
Platelet-derived Growth Factor Induces Interleukin-6 Transcription in Osteoblasts through the Activator Protein-1 Complex and Activating Transcription Factor-2.
N. Franchimont, D. Durant, S. Rydziel, and E. Canalis (1999)
J. Biol. Chem. 274, 6783-6789
   Abstract »    Full Text »    PDF »
Walker 256/S Carcinosarcoma Causes Osteoporosis-like Changes through Ectopical Secretion of Luteinizing Hormone-releasing Hormone.
Y. Waki, M. Nomura, S. Kasugai, K. Ohya, and K.-i. Miyamoto (1999)
Cancer Res. 59, 1219-1224
   Abstract »    Full Text »    PDF »
Macrophage Colony Stimulating-Factor Transcripts Are Differentially Regulated in Rat Bone-Marrow by Gender Hormones.
C. K. Lea, U. Sarma, and A. M. Flanagan (1999)
Endocrinology 140, 273-279
   Abstract »    Full Text »
Association of oestrogen receptor gene polymorphisms with age at onset of rheumatoid arthritis.
T. Ushiyama, K. Mori, K. Inoue, J. Huang, J. Nishioka, and S. Hukuda (1999)
Ann Rheum Dis 58, 7-10
   Abstract »    Full Text »
Soluble IL-6 Receptor Potentiates the Antagonistic Activity of Soluble gp130 on IL-6 Responses.
G. Muller-Newen, A. Kuster, U. Hemmann, R. Keul, U. Horsten, A. Martens, L. Graeve, J. Wijdenes, and P. C. Heinrich (1998)
J. Immunol. 161, 6347-6355
   Abstract »    Full Text »    PDF »
Mode of Action of Interleukin-6 on Mature Osteoclasts. Novel Interactions with Extracellular Ca2+ Sensing in the Regulation of Osteoclastic Bone Resorption.
O. A. Adebanjo, B. S. Moonga, T. Yamate, L. Sun, C. Minkin, E. Abe, and M. Zaidi (1998)
J. Cell Biol. 142, 1347-1356
   Abstract »    Full Text »    PDF »
Interleukin-13 Inhibits Cell Proliferation and Stimulates Interleukin-6 Formation in Isolated Human Osteoblasts.
A. Frost, K. B. Jonsson, H. Brändström, C. Ohlsson, S. Ljunghall, and O. Ljunggren (1998)
J. Clin. Endocrinol. Metab. 83, 3285-3289
   Abstract »    Full Text »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)